| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 81 |
| 1 | FLUOROURACIL | 58 |
| 2 | FLUOROURACIL CREAM, 0.5% | 58 |
| 3 | CYCLOPHOSPHAMIDE | 54 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 54 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 54 |
| 6 | LEVONORGESTREL | 50 |
| 7 | METHOTREXATE SODIUM | 36 |
| 8 | DROSPIRENONE AND ETHINYL ESTRADIOL | 35 |
| 9 | METHOTREXATE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE AND TRETINOIN | 1 | 0.0065 |
| 1 | TRASTUZUMAB-QYYP | 1 | 0.0026 |
| 2 | THIOTEPA | 25 | 0.0026 |
| 3 | CHOLIC ACID | 1 | 0.0025 |
| 4 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 5 | NITISINONE | 2 | 0.0021 |
| 6 | PENICILLIN V POTASSIUM | 5 | 0.0019 |
| 7 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 8 | SOYBEAN OIL | 1 | 0.0015 |
| 9 | CANAKINUMAB | 16 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 97 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 88 |
| 2 | Alkylating Drug [EPC] | 61 |
| 3 | Progestin [EPC] | 60 |
| 4 | Corticosteroid [EPC] | 51 |
| 5 | Progestin-containing Intrauterine System [EPC] | 50 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 35 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 8 | Topoisomerase Inhibitor [EPC] | 31 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 16 | 0.0009 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 4 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 3 | 0.0007 |
| 5 | Recombinant Human Growth Hormone [EPC] | 14 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Actinomycin [EPC] | 1 | 0.0005 |
| 8 | Topoisomerase Inhibitor [EPC] | 31 | 0.0004 |
| 9 | Lipid Emulsion [EPC] | 1 | 0.0004 |